High Rates of Off-label Prescribing and the Urgent Need for a Randomized Clinical Trial

JAMA Cardiol. 2020 Jun 1;5(6):692-693. doi: 10.1001/jamacardio.2020.0612.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticoagulants
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Off-Label Use*
  • Warfarin*

Substances

  • Anticoagulants
  • Warfarin